NasdaqGS - Delayed Quote USD

Mesa Laboratories, Inc. (MLAB)

100.74 +1.12 (+1.12%)
At close: April 19 at 4:00 PM EDT
100.74 0.00 (0.00%)
After hours: April 19 at 4:03 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Gary M. Owens CEO, President & Director 1.02M -- 1968
Mr. John V. Sakys VP, CFO & Chief Accounting Officer 551.4k 1.11M 1969
Mr. Brian David Archbold Senior Vice President of Continuous Improvement 485.59k -- 1976

Mesa Laboratories, Inc.

12100 West Sixth Avenue
Lakewood, CO 80228
United States
303 987 8000 https://www.mesalabs.com
Sector: 
Technology
Full Time Employees: 
698

Description

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Corporate Governance

Mesa Laboratories, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 9; Board: 4; Shareholder Rights: 3; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 24, 2024
Mesa Laboratories, Inc. Earnings Call

Jun 14, 2024

Dividend Date

May 31, 2024

Ex-Dividend Date

Related Tickers

ELSE Electro-Sensors, Inc.
4.1300
+0.24%
 
NOVT Novanta Inc.
149.41
-0.41%
 
IKE.AX ikeGPS Group Limited
0.4000
+2.56%
 
SMIT Schmitt Industries, Inc.
0.0310
0.00%
 
FARO FARO Technologies, Inc.
18.71
+2.13%
 
SCND Scientific Industries, Inc.
1.3000
0.00%
 
VPG Vishay Precision Group, Inc.
33.27
+0.60%
 
KNW Know Labs, Inc.
0.5632
-5.22%
 
MIND MIND Technology, Inc.
4.1900
-0.95%
 
ESE ESCO Technologies Inc.
100.92
+2.27%